| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR SHROOM3 ABI3 SPATA31A3 ANK3 MAP1A MAPT SPATA31A7 KIF1B TOM1 APC SORBS1 DCTN1 SPATA31A6 SPATA31C1 SPATA31A5 KIF24 EML3 SPATA31A1 ALMS1 BRCA2 TTLL6 CLMN SUN2 WASF2 LRRC27 KIF19 CEP295 MYO18B CEP57 PALLD SPATA4 | 4.89e-09 | 1099 | 182 | 32 | GO:0008092 |
| GeneOntologyMolecularFunction | tubulin binding | TPR MAP1A MAPT KIF1B APC DCTN1 KIF24 EML3 ALMS1 BRCA2 TTLL6 SUN2 KIF19 CEP295 CEP57 SPATA4 | 2.05e-06 | 428 | 182 | 16 | GO:0015631 |
| GeneOntologyMolecularFunction | microtubule binding | MAP1A MAPT KIF1B APC DCTN1 KIF24 EML3 ALMS1 SUN2 KIF19 CEP295 CEP57 SPATA4 | 5.27e-06 | 308 | 182 | 13 | GO:0008017 |
| GeneOntologyMolecularFunction | actin binding | SHROOM3 ABI3 SPATA31A3 MAP1A MAPT SPATA31A7 SORBS1 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31A1 CLMN WASF2 LRRC27 MYO18B PALLD | 8.55e-06 | 479 | 182 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | molecular adaptor activity | TPR NCOA3 NCOA6 ABI3 GATAD2A ANK3 MAP1A TCOF1 MAPT ITSN1 BECN2 ZC3H18 SORBS1 SRCAP IFI16 DCTN1 ALKBH5 CREBBP USP21 MLIP TLE2 SUN2 OTUD4 IRS2 NIPBL ZNF541 FOXP3 | 1.03e-04 | 1356 | 182 | 27 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TPR NCOA3 NCOA6 ABI3 GATAD2A ANK3 MAP1A TCOF1 MAPT BECN2 ZC3H18 SORBS1 SRCAP IFI16 ALKBH5 CREBBP USP21 MLIP TLE2 SUN2 IRS2 NIPBL ZNF541 FOXP3 | 1.46e-04 | 1160 | 182 | 24 | GO:0030674 |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulator activity | 5.49e-04 | 18 | 182 | 3 | GO:0035014 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | DNHD1 NCOA3 SPATA31A3 SPATA31A7 ASH1L SPATA31C2 RNF8 APC ADGRG1 SPATA31A6 CIT SPATA31C1 ALKBH5 SPATA31A5 CFAP54 CSF1 SPATA31A1 ALMS1 SBF1 BRCA2 ADGRG2 UMODL1 CFAP221 PLAG1 CEP57 NIPBL CCDC136 ZNF541 KNL1 TDRD12 | 3.63e-07 | 1235 | 181 | 30 | GO:0003006 |
| GeneOntologyBiologicalProcess | spermatogenesis | DNHD1 SPATA31A3 SPATA31A7 SPATA31C2 RNF8 SPATA31A6 CIT SPATA31C1 ALKBH5 SPATA31A5 CFAP54 SPATA31A1 ALMS1 SBF1 BRCA2 ADGRG2 CFAP221 CEP57 CCDC136 ZNF541 KNL1 TDRD12 | 6.58e-07 | 744 | 181 | 22 | GO:0007283 |
| GeneOntologyBiologicalProcess | male gamete generation | DNHD1 SPATA31A3 SPATA31A7 SPATA31C2 RNF8 SPATA31A6 CIT SPATA31C1 ALKBH5 SPATA31A5 CFAP54 SPATA31A1 ALMS1 SBF1 BRCA2 ADGRG2 CFAP221 CEP57 CCDC136 ZNF541 KNL1 TDRD12 | 9.79e-07 | 762 | 181 | 22 | GO:0048232 |
| GeneOntologyBiologicalProcess | sexual reproduction | DNHD1 SPATA31A3 SPATA31A7 ASH1L SPATA31C2 RNF8 FANCM SPATA31A6 CIT SPATA31C1 ALKBH5 SPATA31A5 CFAP54 SPATA31A1 ALMS1 SBF1 BRCA2 ADGRG2 UMODL1 SUN2 CFAP221 XRN1 CEP57 CCDC136 ZNF541 KNL1 TDRD12 | 3.08e-05 | 1312 | 181 | 27 | GO:0019953 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGAP32 ABCA1 PSD ITSN1 RAP1GAP2 ADGRG1 ARHGAP9 TSC2 GMIP CSF1 ARHGAP31 ARHGAP29 | 4.01e-05 | 333 | 181 | 12 | GO:0051056 |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 4.38e-05 | 188 | 181 | 9 | GO:0000724 | |
| GeneOntologyBiologicalProcess | gamete generation | DNHD1 SPATA31A3 SPATA31A7 SPATA31C2 RNF8 SPATA31A6 CIT SPATA31C1 ALKBH5 SPATA31A5 CFAP54 SPATA31A1 ALMS1 SBF1 BRCA2 ADGRG2 CFAP221 CEP57 CCDC136 ZNF541 KNL1 TDRD12 | 5.25e-05 | 982 | 181 | 22 | GO:0007276 |
| GeneOntologyBiologicalProcess | recombinational repair | 5.59e-05 | 194 | 181 | 9 | GO:0000725 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | DNHD1 SPATA31A3 SPATA31A7 ASH1L SPATA31C2 RNF8 SPATA31A6 CIT SPATA31C1 ALKBH5 SPATA31A5 CFAP54 SPATA31A1 ALMS1 SBF1 BRCA2 ADGRG2 UMODL1 CFAP221 CEP57 CCDC136 ZNF541 KNL1 TDRD12 | 1.27e-04 | 1194 | 181 | 24 | GO:0048609 |
| GeneOntologyBiologicalProcess | endosomal transport | ABCA1 ANKFY1 ITSN1 TOM1 WDR81 DCTN1 PIKFYVE WDR91 ALMS1 GCC2 LRBA | 1.28e-04 | 320 | 181 | 11 | GO:0016197 |
| GeneOntologyCellularComponent | nuclear body | SRSF4 GATAD2A EP400 MAPT APBB3 ZC3H18 SRCAP IFI16 ALKBH5 CREBBP REXO1 PALB2 MLIP HOXC10 CSF1 SBF1 TLE2 PLAG1 MNDA CREB3 KNL1 | 5.70e-05 | 903 | 186 | 21 | GO:0016604 |
| Domain | DUF4599 | 6.28e-10 | 12 | 179 | 6 | PF15371 | |
| Domain | DUF4599 | 6.28e-10 | 12 | 179 | 6 | IPR027970 | |
| Domain | LRRC37AB_C | 3.44e-06 | 4 | 179 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 3.44e-06 | 4 | 179 | 3 | PF14914 | |
| Domain | LRRC37_N | 3.44e-06 | 4 | 179 | 3 | IPR032754 | |
| Domain | LRRC37 | 3.44e-06 | 4 | 179 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 3.44e-06 | 4 | 179 | 3 | IPR015753 | |
| Domain | SH3_9 | 1.03e-04 | 78 | 179 | 6 | PF14604 | |
| Domain | ALMS_motif | 2.72e-04 | 3 | 179 | 2 | IPR029299 | |
| Domain | ALMS_motif | 2.72e-04 | 3 | 179 | 2 | PF15309 | |
| Domain | RhoGAP | 3.18e-04 | 62 | 179 | 5 | SM00324 | |
| Domain | RhoGAP | 3.43e-04 | 63 | 179 | 5 | PF00620 | |
| Domain | RhoGAP_dom | 3.69e-04 | 64 | 179 | 5 | IPR000198 | |
| Domain | RHOGAP | 3.69e-04 | 64 | 179 | 5 | PS50238 | |
| Domain | - | 3.69e-04 | 64 | 179 | 5 | 1.10.555.10 | |
| Domain | PH | 3.74e-04 | 229 | 179 | 9 | PF00169 | |
| Domain | TF_T-box | 5.33e-04 | 17 | 179 | 3 | IPR001699 | |
| Domain | TBOX | 5.33e-04 | 17 | 179 | 3 | SM00425 | |
| Domain | TF_T-box_CS | 5.33e-04 | 17 | 179 | 3 | IPR018186 | |
| Domain | - | 5.33e-04 | 17 | 179 | 3 | 2.60.40.820 | |
| Domain | TBOX_3 | 5.33e-04 | 17 | 179 | 3 | PS50252 | |
| Domain | T-box | 5.33e-04 | 17 | 179 | 3 | PF00907 | |
| Domain | TBOX_1 | 5.33e-04 | 17 | 179 | 3 | PS01283 | |
| Domain | TBOX_2 | 5.33e-04 | 17 | 179 | 3 | PS01264 | |
| Domain | HIN_200 | 5.41e-04 | 4 | 179 | 2 | PS50834 | |
| Domain | HSA | 5.41e-04 | 4 | 179 | 2 | SM00573 | |
| Domain | HSA | 5.41e-04 | 4 | 179 | 2 | PS51204 | |
| Domain | GPR1/GPR3/GPR5 | 5.41e-04 | 4 | 179 | 2 | IPR003910 | |
| Domain | HIN | 5.41e-04 | 4 | 179 | 2 | PF02760 | |
| Domain | HIN200/IF120x | 5.41e-04 | 4 | 179 | 2 | IPR004021 | |
| Domain | MLK1/MLK2/MLK4 | 5.41e-04 | 4 | 179 | 2 | IPR016231 | |
| Domain | HSA_dom | 5.41e-04 | 4 | 179 | 2 | IPR014012 | |
| Domain | HSA | 5.41e-04 | 4 | 179 | 2 | PF07529 | |
| Domain | MAP3K10 | 5.41e-04 | 4 | 179 | 2 | IPR015785 | |
| Domain | SH3 | 1.16e-03 | 216 | 179 | 8 | SM00326 | |
| Domain | SH3 | 1.16e-03 | 216 | 179 | 8 | PS50002 | |
| Domain | SH3_domain | 1.30e-03 | 220 | 179 | 8 | IPR001452 | |
| Domain | Nuc_rcpt_coact | 1.34e-03 | 6 | 179 | 2 | IPR009110 | |
| Domain | PH | 1.48e-03 | 278 | 179 | 9 | SM00233 | |
| Domain | C2H2_Znf_fam | 1.51e-03 | 24 | 179 | 3 | IPR027775 | |
| Domain | PH_DOMAIN | 1.52e-03 | 279 | 179 | 9 | PS50003 | |
| Domain | PH_domain | 1.56e-03 | 280 | 179 | 9 | IPR001849 | |
| Domain | Rho_GTPase_activation_prot | 1.58e-03 | 88 | 179 | 5 | IPR008936 | |
| Pubmed | 2.23e-14 | 6 | 187 | 6 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 2.23e-14 | 6 | 187 | 6 | 25930072 | |
| Pubmed | TPR NCOA3 ANKFY1 ZNF280D APC DCTN1 ZEB2 RBM20 PALB2 ALMS1 ZFHX4 BRCA2 GCC2 XRN1 IRS2 LRBA MGA ZNF687 KNL1 | 1.62e-12 | 418 | 187 | 19 | 34709266 | |
| Pubmed | TANC2 TPR NCOA3 ARHGAP32 SHROOM3 ANKFY1 UBAP2 ANK3 TCOF1 NHSL2 ITSN1 WDR81 APC TSC2 SORBS1 DCTN1 CIT ZEB2 WDR91 CNTNAP5 SBF1 TJP1 WASF2 OTUD4 SLC4A4 MGA NIPBL | 2.55e-12 | 963 | 187 | 27 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 NCOA6 ARHGAP32 SHROOM3 UBAP2 MAPT EXPH5 KIF1B PRR5 APC TSC2 SORBS1 DENND2B MAST4 ALMS1 SBF1 TJP1 CLMN XRN1 MAP3K9 IRS2 USP54 MAP3K21 PALLD DYRK2 | 8.40e-12 | 861 | 187 | 25 | 36931259 |
| Pubmed | SPATA31A3 SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A5 SPATA31A1 MYO18B | 3.72e-11 | 24 | 187 | 7 | 32212159 | |
| Pubmed | TANC2 EPC2 PSD GATAD2A EP400 MAP1A TCOF1 MAPT PHRF1 ASH1L RNF213 ZC3H18 SRCAP CREBBP BPTF C1orf226 ALMS1 ZFHX4 SUN2 XRN1 CEP295 IRS2 USP54 MGA ZNF687 KNL1 | 3.73e-10 | 1116 | 187 | 26 | 31753913 | |
| Pubmed | TPR NCOA6 UBAP2 ANK3 EP400 TCOF1 SRCAP DCTN1 CREBBP BPTF ALMS1 TJP1 XRN1 OSBPL11 RPRD2 LRBA MGA PALLD | 1.26e-09 | 549 | 187 | 18 | 38280479 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ENDOD1 SHROOM3 ANK3 TSHZ2 MAPT MYT1 KIF1B TOM1 ASH1L PRR5 ADGRG1 RNF213 SRCIN1 TSEN2 CREBBP DENND2B TASOR2 LRCH3 HIVEP3 BPTF TJP1 CLMN GCC2 LRRC27 SLX4IP RPRD2 VGLL4 LRBA CRAMP1 | 2.02e-09 | 1489 | 187 | 29 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 NCOA6 SHROOM3 EP400 APBB3 RAP1GAP2 TSC2 ITGA5 SRCAP TMEM127 DCTN1 CIT EML3 REXO1 KCNH3 PIKFYVE HIVEP3 SBF1 RRP12 IRS2 LRBA CRAMP1 ZNF687 CREB3 | 7.32e-09 | 1105 | 187 | 24 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR NCOA3 NCOA6 EP400 TCOF1 MAPT ITSN1 KIF1B PHRF1 ZC3H18 IFI16 REXO1 PALB2 BPTF RRP12 OSBPL11 OTUD4 IRS2 NIPBL ZNF687 | 8.43e-09 | 774 | 187 | 20 | 15302935 |
| Pubmed | TANC2 ENDOD1 ARHGAP32 EXPH5 GRAMD1A RNF8 RNF213 ENPP4 FANCM REXO1 PIKFYVE HIVEP3 ALMS1 SUN2 MGA PALLD | 1.25e-08 | 493 | 187 | 16 | 15368895 | |
| Pubmed | TANC2 NCOA3 NCOA6 ARHGAP32 ANKFY1 GATAD2A LRRC37A3 MBOAT7 MUC16 ITGA5 CREBBP GCC2 OTUD4 CEP295 IRS2 NIPBL ZNF687 KNL1 | 1.29e-08 | 638 | 187 | 18 | 31182584 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EP400 MAP1A TCOF1 ITSN1 KIF1B RNF8 APC ZC3H18 SORBS1 SRCAP ALKBH5 CREBBP RBM20 PIKFYVE ALMS1 BRCA2 KNL1 | 2.35e-08 | 588 | 187 | 17 | 38580884 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR UBAP2 EP400 MAP1A TCOF1 SRCAP DCTN1 CRACD ALMS1 TJP1 CLMN WASF2 RRP12 XRN1 OSBPL11 RPRD2 IRS2 LRBA NIPBL PALLD KNL1 | 3.82e-08 | 934 | 187 | 21 | 33916271 |
| Pubmed | NCOA3 EPC2 NCOA6 ARHGAP32 UBAP2 GATAD2A EP400 ZC3H18 SRCAP CIT CREBBP ZEB2 RBM20 BPTF ALMS1 ZFHX4 RRP12 XRN1 OTUD4 SLX4IP RPRD2 VGLL4 USP54 MGA NIPBL ZNF687 | 5.86e-08 | 1429 | 187 | 26 | 35140242 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | MAP1A ZEB2 ALMS1 ARHGAP31 TJP1 XRN1 ARHGAP29 RPRD2 MGA PALLD | 6.76e-08 | 184 | 187 | 10 | 32908313 |
| Pubmed | TPR ARHGAP32 ANK3 MAP1A EXPH5 ITSN1 APC RAP1GAP2 SORBS1 DCTN1 CREBBP ARHGAP31 SLC4A4 MAP3K21 MGA | 6.99e-08 | 486 | 187 | 15 | 20936779 | |
| Pubmed | TBX15 TCEA3 NCOA3 ANKFY1 ZNF280D ZSCAN5A MYT1 ASH1L SRCAP HIVEP3 BPTF ZSCAN5B HEY1 PLAG1 OLIG1 TBX20 MGA ZNF687 CREB3 | 8.88e-08 | 808 | 187 | 19 | 20412781 | |
| Pubmed | TPR NCOA3 GATAD2A TCOF1 APC IFI16 GCC2 RRP12 OSBPL11 OTUD4 RPRD2 IRS2 NIPBL PALLD ZNF687 | 1.09e-07 | 503 | 187 | 15 | 16964243 | |
| Pubmed | NCOA6 ANK3 EXPH5 ITSN1 TOM1 ASH1L ARHGAP9 DCTN1 CREBBP DENND2B ZEB2 MAST4 HEY1 PLAG1 MGA KNL1 | 1.50e-07 | 591 | 187 | 16 | 15231748 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ARHGAP32 SHROOM3 ITSN1 KIF1B APC SORBS1 ATE1 DCTN1 MAST4 ALMS1 BRCA2 TJP1 WASF2 XRN1 ARHGAP29 IFFO2 CEP295 USP54 MGA | 2.04e-07 | 853 | 187 | 19 | 28718761 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX15 NCOA3 UNCX TSHZ2 MYT1 ASH1L ZEB2 HIVEP3 HOXC10 ZFHX4 HEY1 PLAG1 OLIG1 TBX20 MGA CRAMP1 ZNF541 CREB3 FOXP3 | 5.24e-07 | 908 | 187 | 19 | 19274049 |
| Pubmed | 6.09e-07 | 4 | 187 | 3 | 22419166 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ARHGAP32 ABCA1 GATAD2A TSHZ2 ZSCAN5A WDR81 SRCAP CRACD BPTF ZSCAN5B IFFO2 MGA | 7.24e-07 | 363 | 187 | 12 | 14691545 |
| Pubmed | TANC2 ARHGAP32 ANK3 MAP1A MBOAT7 MAPT ITSN1 KIF1B TOM1 APC SORBS1 SRCIN1 DCTN1 CIT LRCH3 CRACD MLIP SBF1 TJP1 CLMN XRN1 OTUD4 USP54 SLC4A4 | 8.52e-07 | 1431 | 187 | 24 | 37142655 | |
| Pubmed | 8.77e-07 | 60 | 187 | 6 | 34761192 | ||
| Pubmed | TANC2 SHROOM3 KIF1B APC TSC2 SORBS1 LRCH3 ALMS1 TJP1 CEP295 IRS2 USP54 MAP3K21 | 1.02e-06 | 446 | 187 | 13 | 24255178 | |
| Pubmed | 1.30e-06 | 101 | 187 | 7 | 10997877 | ||
| Pubmed | 1.52e-06 | 5 | 187 | 3 | 23038782 | ||
| Pubmed | 1.80e-06 | 263 | 187 | 10 | 34702444 | ||
| Pubmed | UBAP2 EP400 ITSN1 APC RNF213 PIKFYVE ALMS1 TJP1 CLMN XRN1 RPRD2 CEP295 USP54 MGA ZNF687 KNL1 | 2.53e-06 | 733 | 187 | 16 | 34672954 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.46e-06 | 283 | 187 | 10 | 30585729 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA3 EPC2 NCOA6 EP400 CREBBP ZEB2 BPTF ALMS1 ZFHX4 MGA NIPBL | 3.54e-06 | 351 | 187 | 11 | 38297188 |
| Pubmed | 3.55e-06 | 222 | 187 | 9 | 37071664 | ||
| Pubmed | MBOAT7 GRAMD1A TOM1 WDR81 TSC2 ITGA5 LRCH3 RPS6KC1 PIKFYVE WDR91 SUN2 OSBPL11 LRBA | 3.88e-06 | 504 | 187 | 13 | 34432599 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 ARHGAP32 SHROOM3 UBAP2 ANK3 EP400 MAP1A TCOF1 ITSN1 TASOR2 ARHGAP31 MGA | 4.17e-06 | 430 | 187 | 12 | 35044719 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ANKFY1 ANK3 ZC3H18 ITGA5 F5 ZFHX4 GCC2 IRS2 MYO18B MAP3K21 PALLD | 4.62e-06 | 361 | 187 | 11 | 26167880 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.90e-06 | 231 | 187 | 9 | 16452087 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | UBAP2 EP400 TCOF1 APC SRCAP LRCH3 RPS6KC1 SBF1 RRP12 RPRD2 USP54 ZNF687 | 5.26e-06 | 440 | 187 | 12 | 34244565 |
| Pubmed | SHROOM3 ANK3 EP400 TCOF1 KIF1B APC MUC16 RNF213 TASOR2 TJP1 GCC2 WASF2 XRN1 IFFO2 LRBA MGA | 5.29e-06 | 777 | 187 | 16 | 35844135 | |
| Pubmed | NCOA6 SHROOM3 UBAP2 EP400 PHRF1 SRCIN1 MAST4 SBF1 ARHGAP31 RPRD2 CEP57 CRAMP1 ZNF687 | 6.53e-06 | 529 | 187 | 13 | 14621295 | |
| Pubmed | MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks. | 6.62e-06 | 23 | 187 | 4 | 20332121 | |
| Pubmed | 7.02e-06 | 130 | 187 | 7 | 12421765 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPC2 NCOA6 SRSF4 GATAD2A EP400 TCOF1 ZSCAN5A PHRF1 ZC3H18 SRCAP FANCM IFI16 PALB2 BPTF HOXC10 SUN2 RRP12 RPRD2 MGA NIPBL ZNF687 | 7.18e-06 | 1294 | 187 | 21 | 30804502 |
| Pubmed | TPR ARHGAP32 ANK3 TCOF1 KIF1B APC ZC3H18 ATE1 WASF2 XRN1 ARHGAP29 IRS2 LRBA MAP3K21 PALLD | 7.51e-06 | 708 | 187 | 15 | 39231216 | |
| Pubmed | 8.40e-06 | 8 | 187 | 3 | 24141787 | ||
| Pubmed | Rheb1 is required for mTORC1 and myelination in postnatal brain development. | 9.37e-06 | 25 | 187 | 4 | 21238928 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA3 EPC2 GATAD2A EP400 APC CREBBP ZEB2 RBM20 ZFHX4 USP54 MGA | 1.16e-05 | 398 | 187 | 11 | 35016035 |
| Pubmed | BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation. | 1.25e-05 | 9 | 187 | 3 | 30704900 | |
| Pubmed | ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. | 1.29e-05 | 27 | 187 | 4 | 17525332 | |
| Pubmed | ANKFY1 EP400 KIF1B RAP1GAP2 SORBS1 ZEB2 CRACD GCC2 RRP12 OTUD4 CIPC | 1.42e-05 | 407 | 187 | 11 | 12693553 | |
| Pubmed | ARHGAP32 SHROOM3 MAP1A PHRF1 ZC3H18 TASOR2 LRCH3 TTLL6 GCC2 RRP12 MROH7 MYO18B | 1.74e-05 | 496 | 187 | 12 | 31343991 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR NCOA6 UBAP2 SRSF4 GATAD2A EP400 ZC3H18 FANCM TASOR2 BPTF BRCA2 TJP1 SLX4IP RPRD2 MGA NIPBL KNL1 | 1.74e-05 | 954 | 187 | 17 | 36373674 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.76e-05 | 341 | 187 | 10 | 32971831 | |
| Pubmed | 1.79e-05 | 10 | 187 | 3 | 23064749 | ||
| Pubmed | 2.07e-05 | 103 | 187 | 6 | 10819331 | ||
| Pubmed | ANK3 TCOF1 ITSN1 KIF1B ASH1L APBB3 APC RAP1GAP2 TSC2 SORBS1 DCTN1 CIT CREBBP ZEB2 HEY1 TJP1 CIPC USP54 LRBA NIPBL | 2.19e-05 | 1285 | 187 | 20 | 35914814 | |
| Pubmed | 2.40e-05 | 157 | 187 | 7 | 30186101 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 2.40e-05 | 157 | 187 | 7 | 30686591 | |
| Pubmed | Transcriptional repression by the T-box proteins Tbx18 and Tbx15 depends on Groucho corepressors. | 2.45e-05 | 11 | 187 | 3 | 17584735 | |
| Pubmed | Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. | 2.88e-05 | 2 | 187 | 2 | 17200672 | |
| Pubmed | Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma. | 2.88e-05 | 2 | 187 | 2 | 35762214 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 25099575 | ||
| Pubmed | Fanconi anemia gene mutations are not involved in sporadic Wilms tumor. | 2.88e-05 | 2 | 187 | 2 | 20589654 | |
| Pubmed | Identification of the MMRN1 binding region within the C2 domain of human factor V. | 2.88e-05 | 2 | 187 | 2 | 15452129 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 17420451 | ||
| Pubmed | Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. | 2.88e-05 | 2 | 187 | 2 | 20927582 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 7806273 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 28675294 | ||
| Pubmed | PALB2 regulates recombinational repair through chromatin association and oligomerization. | 2.88e-05 | 2 | 187 | 2 | 19423707 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 36402190 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 34687993 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 17932487 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 21832836 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 21349274 | ||
| Pubmed | USP21 prevents the generation of T-helper-1-like Treg cells. | 2.88e-05 | 2 | 187 | 2 | 27857073 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 20872766 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 8758910 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 19570783 | ||
| Pubmed | ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits. | 2.88e-05 | 2 | 187 | 2 | 30421101 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 16707491 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 30770747 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 22194698 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 38481816 | ||
| Pubmed | The catalytic subunit of the SWR1 remodeler is a histone chaperone for the H2A.Z-H2B dimer. | 2.88e-05 | 2 | 187 | 2 | 24507717 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 33307343 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 34320348 | ||
| Pubmed | Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. | 2.88e-05 | 2 | 187 | 2 | 22265015 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 19609323 | ||
| Pubmed | Human platelets contain forms of factor V in disulfide-linkage with multimerin. | 2.88e-05 | 2 | 187 | 2 | 15583744 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 11215675 | ||
| Pubmed | A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance. | 2.88e-05 | 2 | 187 | 2 | 21637299 | |
| Pubmed | Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction. | 2.88e-05 | 2 | 187 | 2 | 30410870 | |
| Pubmed | Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation. | 2.88e-05 | 2 | 187 | 2 | 27383765 | |
| Pubmed | Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin. | 2.88e-05 | 2 | 187 | 2 | 21632823 | |
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 28194753 | ||
| Pubmed | 2.88e-05 | 2 | 187 | 2 | 11744688 | ||
| Pubmed | MRG15 is a novel PALB2-interacting factor involved in homologous recombination. | 3.25e-05 | 12 | 187 | 3 | 19553677 | |
| Pubmed | 3.30e-05 | 226 | 187 | 8 | 31452512 | ||
| Interaction | YWHAH interactions | TANC2 NCOA3 NCOA6 ARHGAP32 SHROOM3 UBAP2 MAPT NHSL2 EXPH5 KIF1B PRR5 PLEKHA4 APC TSC2 SORBS1 DCTN1 CREBBP DENND2B EML3 USP21 MAST4 ALMS1 SBF1 TJP1 CLMN WASF2 XRN1 MAP3K9 IRS2 USP54 LRBA MAP3K21 PALLD | 1.42e-09 | 1102 | 184 | 33 | int:YWHAH |
| Interaction | YWHAG interactions | TANC2 NCOA6 ARHGAP32 SHROOM3 UBAP2 MAPT NHSL2 EXPH5 KIF1B PRR5 PLEKHA4 APC TSC2 SORBS1 IFI16 DENND2B EML3 LRCH3 USP21 CRACD HOXC10 MAST4 ALMS1 SBF1 TJP1 CLMN GCC2 WASF2 ARHGAP29 MAP3K9 IRS2 LTB4R USP54 LRBA MAP3K21 | 2.32e-09 | 1248 | 184 | 35 | int:YWHAG |
| Interaction | SFN interactions | TANC2 NCOA6 ARHGAP32 SHROOM3 SRSF4 MAP1A MAPT EXPH5 KIF1B PRR5 RNF8 APC TSC2 ZC3H18 SORBS1 DENND2B MAST4 ALMS1 TJP1 CLMN IRS2 USP54 MAP3K21 PALLD | 2.11e-08 | 692 | 184 | 24 | int:SFN |
| Interaction | RCOR1 interactions | TPR ANKFY1 GATAD2A ZSCAN5A MYT1 APC DCTN1 ZEB2 RBM20 PALB2 ALMS1 ZFHX4 BRCA2 GCC2 XRN1 LRBA MGA ZNF687 KNL1 FOXP3 | 2.84e-08 | 494 | 184 | 20 | int:RCOR1 |
| Interaction | KDM1A interactions | TPR NCOA3 ANKFY1 ZNF280D EP400 MAPT ZSCAN5A MYT1 PLEKHA4 APC DCTN1 CIT ZEB2 RBM20 PALB2 ALMS1 ZFHX4 BRCA2 GCC2 XRN1 ARHGAP29 IRS2 LRBA MGA CEP57 ZNF687 KNL1 FOXP3 | 3.40e-08 | 941 | 184 | 28 | int:KDM1A |
| Interaction | YWHAQ interactions | TANC2 TPR NCOA3 NCOA6 ARHGAP32 SHROOM3 UBAP2 ZNF280D MAPT EXPH5 KIF1B PRR5 PLEKHA4 RNF8 APC TSC2 SORBS1 IFI16 DENND2B EML3 MAST4 SBF1 TJP1 WASF2 MAP3K9 IRS2 USP54 LRBA MAP3K21 | 3.47e-07 | 1118 | 184 | 29 | int:YWHAQ |
| Interaction | ZYX interactions | TANC2 ARHGAP32 SHROOM3 ITSN1 PLEKHA4 APC ARHGAP9 SORBS1 CIT CRACD ALMS1 ARHGAP31 TJP1 CLMN OSBPL11 | 3.77e-07 | 329 | 184 | 15 | int:ZYX |
| Interaction | YWHAE interactions | TANC2 ARHGAP32 SHROOM3 SRSF4 MAPT EXPH5 KIF1B PRR5 PLEKHA4 RNF8 APC RAP1GAP2 TSC2 ZC3H18 SORBS1 SRCIN1 DCTN1 DENND2B LRCH3 USP21 CRACD MAST4 SBF1 GCC2 MAP3K9 IRS2 USP54 LRBA MAP3K21 MGA CEP57 | 3.82e-07 | 1256 | 184 | 31 | int:YWHAE |
| Interaction | CSNK2A1 interactions | ABCA1 GATAD2A TCOF1 MAPT ZSCAN5A GRAMD1A KIF1B PHRF1 PLEKHA4 APC ZC3H18 ANKRD36C IFI16 F5 CIT ALKBH5 CREBBP KIF24 ZEB2 HEY1 RRP12 RPRD2 USP54 MGA CEP57 ZNF687 | 6.25e-07 | 956 | 184 | 26 | int:CSNK2A1 |
| Interaction | PHF21A interactions | TPR ANKFY1 APC ZEB2 RBM20 ALMS1 ZFHX4 BRCA2 GCC2 XRN1 IRS2 LRBA MGA ZNF687 KNL1 | 6.39e-07 | 343 | 184 | 15 | int:PHF21A |
| Interaction | YWHAZ interactions | TANC2 ARHGAP32 SHROOM3 MAPT EXPH5 KIF1B PRR5 PLEKHA4 RNF8 APC RAP1GAP2 TSC2 ZC3H18 SORBS1 IFI16 DCTN1 DENND2B EML3 USP21 CRACD MAST4 ANKRD34B SBF1 TJP1 GCC2 ARHGAP29 MAP3K9 OTUD4 IRS2 USP54 MAP3K21 | 1.09e-06 | 1319 | 184 | 31 | int:YWHAZ |
| Interaction | SYNE3 interactions | TANC2 ARHGAP32 SHROOM3 EXPH5 GRAMD1A APC SORBS1 PALB2 ALMS1 BRCA2 ERAP2 CLMN SUN2 ARHGAP29 CEP295 USP54 | 3.37e-06 | 444 | 184 | 16 | int:SYNE3 |
| Interaction | NUP43 interactions | NCOA6 GATAD2A ZNF280D EP400 PHRF1 ASH1L APC ZC3H18 CCDC168 SRCAP IFI16 CIT TASOR2 BPTF BRCA2 MGA NIPBL ZNF687 KNL1 | 4.78e-06 | 625 | 184 | 19 | int:NUP43 |
| Interaction | HDAC1 interactions | TPR ANKFY1 GATAD2A EP400 MYT1 PLEKHA4 APC DCTN1 CIT CREBBP ZEB2 RBM20 PALB2 LRCH3 BPTF ALMS1 ZFHX4 BRCA2 GCC2 XRN1 IRS2 LRBA MGA ZNF687 KNL1 FOXP3 | 9.21e-06 | 1108 | 184 | 26 | int:HDAC1 |
| Interaction | HNF1B interactions | 1.01e-05 | 190 | 184 | 10 | int:HNF1B | |
| Interaction | PRELID2 interactions | 1.46e-05 | 17 | 184 | 4 | int:PRELID2 | |
| Interaction | CFAP184 interactions | 1.85e-05 | 162 | 184 | 9 | int:CFAP184 | |
| Interaction | PIPSL interactions | ITSN1 KIF1B ASH1L PLEKHA4 SRCAP EML3 C1orf226 ALMS1 SBF1 MGA CRAMP1 | 2.12e-05 | 252 | 184 | 11 | int:PIPSL |
| Interaction | NCAPH2 interactions | 2.58e-05 | 169 | 184 | 9 | int:NCAPH2 | |
| Interaction | TRIM52 interactions | 3.08e-05 | 133 | 184 | 8 | int:TRIM52 | |
| Interaction | CSNK2A2 interactions | ABCA1 GATAD2A EP400 TCOF1 ZSCAN5A GRAMD1A KIF1B PHRF1 ASH1L PLEKHA4 ZC3H18 ANKRD36C IFI16 CREBBP ZEB2 SBF1 ARHGAP29 MGA ZNF687 | 3.31e-05 | 718 | 184 | 19 | int:CSNK2A2 |
| Interaction | TFF1 interactions | 3.45e-05 | 41 | 184 | 5 | int:TFF1 | |
| Interaction | WWTR1 interactions | NCOA6 UBAP2 ANK3 EP400 SRCAP DCTN1 CREBBP BPTF ALMS1 TJP1 XRN1 OSBPL11 RPRD2 LRBA | 3.50e-05 | 422 | 184 | 14 | int:WWTR1 |
| Interaction | CEP152 interactions | 4.06e-05 | 179 | 184 | 9 | int:CEP152 | |
| Interaction | HNF4A interactions | NCOA3 EPC2 NCOA6 EP400 SRCAP CREBBP ZEB2 BPTF SLX4IP MGA NIPBL | 4.71e-05 | 275 | 184 | 11 | int:HNF4A |
| Interaction | TERF2IP interactions | NCOA6 GATAD2A EP400 ZC3H18 SRCAP CREBBP TASOR2 BPTF BRCA2 TJP1 SLX4IP VGLL4 MGA NIPBL ZNF687 KNL1 | 4.92e-05 | 552 | 184 | 16 | int:TERF2IP |
| Interaction | YWHAB interactions | TANC2 ARHGAP32 SHROOM3 MAPT EXPH5 KIF1B PRR5 PLEKHA4 APC TSC2 SORBS1 DCTN1 DENND2B EML3 MAST4 TJP1 GCC2 SUN2 WASF2 MAP3K9 IRS2 USP54 MAP3K21 | 5.35e-05 | 1014 | 184 | 23 | int:YWHAB |
| Interaction | CSNK2B interactions | EPC2 GATAD2A EP400 TCOF1 ZSCAN5A ITSN1 PHRF1 PLEKHA4 APC ZC3H18 IFI16 CREBBP ZEB2 HEY1 TJP1 CIPC ZNF687 | 6.25e-05 | 625 | 184 | 17 | int:CSNK2B |
| Interaction | CLASP2 interactions | 6.27e-05 | 147 | 184 | 8 | int:CLASP2 | |
| Interaction | ANKFY1 interactions | ANKFY1 PLEKHA4 IFI16 DCTN1 RPS6KC1 WDR91 MAST4 ALMS1 GCC2 TLE2 | 6.48e-05 | 236 | 184 | 10 | int:ANKFY1 |
| Interaction | TOP3B interactions | TANC2 NCOA6 SHROOM3 UBAP2 EP400 KIF1B PLEKHA4 APBB3 RAP1GAP2 TSC2 ITGA5 SRCAP TMEM127 DCTN1 CIT EML3 REXO1 KCNH3 PIKFYVE HIVEP3 SBF1 RRP12 XRN1 OTUD4 IRS2 LRBA CRAMP1 ZNF687 CREB3 | 6.77e-05 | 1470 | 184 | 29 | int:TOP3B |
| Interaction | PLK1 interactions | DNHD1 ANK3 NHSL2 MYT1 ITSN1 PLEKHA4 APC TSC2 DCTN1 KIF24 C1orf226 BRCA2 SLX4IP IRS2 FOXP3 | 7.24e-05 | 510 | 184 | 15 | int:PLK1 |
| Interaction | NAA40 interactions | TPR UBAP2 EP400 MAP1A TCOF1 SRCAP DCTN1 CIT CRACD ALMS1 TJP1 CLMN WASF2 RRP12 XRN1 OSBPL11 RPRD2 IRS2 LRBA NIPBL PALLD KNL1 | 8.87e-05 | 978 | 184 | 22 | int:NAA40 |
| Interaction | ELF4 interactions | 9.01e-05 | 115 | 184 | 7 | int:ELF4 | |
| Interaction | BICD1 interactions | ARHGAP32 SHROOM3 SORBS1 DCTN1 CIT TJP1 WASF2 XRN1 ARHGAP29 USP54 | 1.04e-04 | 250 | 184 | 10 | int:BICD1 |
| Interaction | WDR3 interactions | 1.14e-04 | 160 | 184 | 8 | int:WDR3 | |
| Interaction | SP7 interactions | NCOA3 EPC2 NCOA6 EP400 CREBBP ZEB2 RBM20 ZFHX4 RPRD2 MGA NIPBL | 1.15e-04 | 304 | 184 | 11 | int:SP7 |
| Interaction | NIN interactions | APC DCTN1 CIT ALMS1 BRCA2 TJP1 XRN1 IFFO2 CEP295 USP54 MGA PALLD | 1.19e-04 | 359 | 184 | 12 | int:NIN |
| Interaction | FLOT1 interactions | ARHGAP32 ABCA1 ANK3 EP400 ITSN1 PLEKHA4 APC SORBS1 GMIP CIT C1orf226 TJP1 OTUD4 USP54 | 1.24e-04 | 475 | 184 | 14 | int:FLOT1 |
| Interaction | SYNE1 interactions | 1.37e-04 | 123 | 184 | 7 | int:SYNE1 | |
| Interaction | MORF4L2 interactions | 1.59e-04 | 168 | 184 | 8 | int:MORF4L2 | |
| Interaction | ELF1 interactions | 1.60e-04 | 126 | 184 | 7 | int:ELF1 | |
| Interaction | POLR1G interactions | GATAD2A EP400 TCOF1 PLEKHA4 RNF8 ZC3H18 SRCAP CIT ZEB2 BPTF RRP12 RPRD2 MGA NIPBL | 1.67e-04 | 489 | 184 | 14 | int:POLR1G |
| Interaction | DYRK1A interactions | TPR SRSF4 TCOF1 MAPT PLEKHA4 TSC2 CIT CREBBP KIF24 LRCH3 C1orf226 XRN1 USP54 LRBA PALLD | 1.73e-04 | 552 | 184 | 15 | int:DYRK1A |
| Interaction | EGR2 interactions | 1.80e-04 | 171 | 184 | 8 | int:EGR2 | |
| Interaction | BRCA1 interactions | DNHD1 TPR NCOA3 UBAP2 ZNF280D TCOF1 MAPT KIF1B PRR5 FANCM IFI16 DCTN1 CIT CREBBP PALB2 BPTF ALMS1 BRCA2 SLX4IP OLIG1 MAP3K21 NIPBL PALLD SPATA4 KNL1 | 1.82e-04 | 1249 | 184 | 25 | int:BRCA1 |
| Interaction | TLE3 interactions | TBX15 NCOA3 ANK3 ATE1 CREBBP RBM20 BRCA2 TLE2 OTUD4 TBX20 NIPBL KNL1 | 1.84e-04 | 376 | 184 | 12 | int:TLE3 |
| Interaction | CKAP5 interactions | TPR MAPT PLEKHA4 SRCIN1 IFI16 DCTN1 CIT USP21 NIPBL MPI FOXP3 | 1.90e-04 | 322 | 184 | 11 | int:CKAP5 |
| Interaction | CEP135 interactions | ARHGAP32 SHROOM3 APC ALMS1 BRCA2 TJP1 XRN1 ARHGAP29 CEP295 USP54 | 2.08e-04 | 272 | 184 | 10 | int:CEP135 |
| Interaction | TEAD1 interactions | 2.19e-04 | 176 | 184 | 8 | int:TEAD1 | |
| Interaction | H2BC21 interactions | EPC2 GATAD2A ZNF280D EP400 RNF8 ZC3H18 SRCAP IFI16 CREBBP PALB2 BPTF MAP3K9 CRYBG1 RPRD2 NIPBL ZNF687 DYRK2 | 2.27e-04 | 696 | 184 | 17 | int:H2BC21 |
| Interaction | NR3C1 interactions | TANC2 NCOA3 NCOA6 ARHGAP32 ANKFY1 GATAD2A LRRC37A3 MBOAT7 PLEKHA4 MUC16 ITGA5 CREBBP IFNGR2 GCC2 OTUD4 CEP295 IRS2 NIPBL ZNF687 KNL1 FOXP3 | 2.31e-04 | 974 | 184 | 21 | int:NR3C1 |
| Interaction | IQCK interactions | 2.47e-04 | 3 | 184 | 2 | int:IQCK | |
| Interaction | WDR91 interactions | 2.52e-04 | 34 | 184 | 4 | int:WDR91 | |
| Interaction | PFN1 interactions | TPR ANKFY1 MAP1A ITSN1 PLEKHA4 APC ZC3H18 ALMS1 TJP1 GCC2 WASF2 ARHGAP29 PALLD ZNF541 | 2.52e-04 | 509 | 184 | 14 | int:PFN1 |
| Interaction | UPF3B interactions | 2.56e-04 | 136 | 184 | 7 | int:UPF3B | |
| Interaction | CNOT9 interactions | 2.82e-04 | 231 | 184 | 9 | int:CNOT9 | |
| Interaction | KDM5C interactions | 2.92e-04 | 139 | 184 | 7 | int:KDM5C | |
| Cytoband | 1q22 | 8.89e-05 | 57 | 187 | 4 | 1q22 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.30e-05 | 50 | 110 | 5 | 721 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.76e-05 | 206 | 110 | 8 | 682 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 9.45e-05 | 15 | 110 | 3 | 529 | |
| GeneFamily | T-boxes | 1.67e-04 | 18 | 110 | 3 | 766 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 2.32e-04 | 20 | 110 | 3 | 548 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 3.62e-04 | 5 | 110 | 2 | 995 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 7.55e-04 | 7 | 110 | 2 | 917 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.39e-04 | 181 | 110 | 6 | 694 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.28e-03 | 9 | 110 | 2 | 1230 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.75e-03 | 46 | 110 | 3 | 622 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.12e-03 | 53 | 110 | 3 | 532 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.70e-03 | 17 | 110 | 2 | 486 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.54e-06 | 199 | 184 | 10 | M5893 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR NCOA3 ABI3 EP400 GRAMD1A ASH1L RNF213 ARHGAP9 GMIP IFI16 CREBBP EML3 ZEB2 LAX1 PIKFYVE HIVEP3 BPTF CSF1 ERAP2 SUN2 XRN1 OTUD4 CRYBG1 AKAP10 LRBA NIPBL DYRK2 | 5.92e-06 | 1492 | 184 | 27 | M40023 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 8.05e-06 | 189 | 184 | 9 | M3112 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS | 1.55e-05 | 113 | 184 | 7 | M43610 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ENDOD1 SHROOM3 ABI3 MAPT ITSN1 KIF1B ASH1L SORBS1 ENPP4 IFI16 CREBBP DENND2B ZEB2 MAST4 ARHGAP31 ARHGAP29 LRBA MNDA PALLD | 1.71e-05 | 888 | 184 | 19 | MM1018 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ENDOD1 SHROOM3 ABI3 MAPT ITSN1 KIF1B ASH1L SORBS1 ENPP4 IFI16 CREBBP DENND2B ZEB2 MAST4 ARHGAP31 ARHGAP29 LRBA PALLD | 3.50e-05 | 854 | 184 | 18 | M1533 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 NHSL2 KIF1B ASH1L SRCAP CREBBP ZEB2 KCNH3 MAST4 CLMN CEP295 VGLL4 CEP57 KNL1 | 5.32e-09 | 259 | 178 | 15 | gudmap_developingGonad_e12.5_epididymis_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 NHSL2 KIF1B ASH1L SRCAP CIT CREBBP ZEB2 MAST4 CLMN CEP295 VGLL4 CEP57 RBM18 | 1.31e-08 | 277 | 178 | 15 | gudmap_developingGonad_e12.5_ovary_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 ZNF280D NHSL2 KIF1B ASH1L RNF213 ENPP4 SRCAP CIT CREBBP ZEB2 MMRN1 IFNGR2 MAST4 ZFHX4 CLMN ARHGAP29 CEP295 VGLL4 TBX20 MGA CEP57 RBM18 TDRD12 | 1.64e-08 | 804 | 178 | 25 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 KIF1B ASH1L SRCAP CIT CREBBP ZEB2 KCNH3 MAST4 ARHGAP31 CLMN CEP295 VGLL4 | 1.15e-07 | 281 | 178 | 14 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 KIF1B ASH1L SRCAP CIT ZEB2 KCNH3 MAST4 ARHGAP31 CLMN CEP295 VGLL4 CEP57 | 1.31e-07 | 284 | 178 | 14 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 NHSL2 ITSN1 KIF1B ASH1L SRCAP CIT CREBBP ZEB2 MAST4 CEP295 VGLL4 CEP57 | 6.21e-07 | 323 | 178 | 14 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 TSHZ2 NHSL2 KIF1B ASH1L SRCAP CIT CREBBP ZEB2 KCNH3 HOXC10 MAST4 ADGRG2 ARHGAP31 CLMN CEP295 VGLL4 MAP3K21 MGA CEP57 KNL1 | 8.30e-07 | 790 | 178 | 22 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NCOA3 ENDOD1 ANKFY1 ZNF280D TSHZ2 NHSL2 KIF1B ASH1L SRCAP CREBBP ZEB2 KCNH3 HIVEP3 MAST4 ADGRG2 ARHGAP31 CLMN CEP295 VGLL4 MAP3K21 MGA CEP57 | 1.04e-06 | 801 | 178 | 22 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 NHSL2 KIF1B ASH1L RNF213 ENPP4 SRCAP CREBBP ZEB2 KCNH3 MAST4 HEY1 CLMN CEP295 VGLL4 TBX20 MAP3K21 MGA CEP57 KNL1 TDRD12 | 1.16e-06 | 806 | 178 | 22 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 ZNF280D NHSL2 ITSN1 KIF1B ASH1L ENPP4 SRCAP CIT CREBBP ZEB2 MMRN1 HOXC10 MAST4 ZFHX4 CLMN CEP295 VGLL4 TBX20 MGA CEP57 | 1.39e-06 | 815 | 178 | 22 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 TSHZ2 NHSL2 KIF1B ASH1L SRCAP CIT CREBBP ZEB2 KCNH3 MAST4 ADGRG2 ARHGAP31 CLMN CEP295 VGLL4 MAP3K21 MGA CEP57 KNL1 | 3.72e-06 | 799 | 178 | 21 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 KIF1B ASH1L RNF213 ENPP4 SRCAP PALB2 TASOR2 STRADB MAST4 ALMS1 BRCA2 ARHGAP29 CEP295 VGLL4 MGA CEP57 ZNF541 TDRD12 | 8.59e-06 | 776 | 178 | 20 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | NHSL2 ASH1L RNF213 SRCAP ZEB2 MMRN1 MAST4 ZFHX4 CEP295 VGLL4 TBX20 MGA CEP57 TDRD12 | 9.63e-06 | 409 | 178 | 14 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TPR EPC2 ZNF280D APC RNF213 CIT ZFHX4 BRCA2 GCC2 CEP295 LRBA MGA NIPBL KNL1 | 1.78e-05 | 432 | 178 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TANC2 TPR ABCA1 GATAD2A ANK3 MBOAT7 KIF1B APC ZEB2 OTUD4 PLAG1 AKAP10 TBX20 | 2.33e-05 | 385 | 178 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.83e-05 | 186 | 178 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | NCOA6 ARHGAP32 ZNF280D ASH1L C11orf24 CIT BRCA2 GCC2 LRBA NIPBL RBM18 | 3.64e-05 | 291 | 178 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | NCOA3 ANKFY1 NHSL2 ASH1L SRCAP CREBBP ZEB2 MAST4 ADGRG2 CLMN CEP295 MGA CEP57 | 4.81e-05 | 413 | 178 | 13 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TPR EPC2 NCOA6 ZNF280D UNCX TCOF1 PRR5 APC ADGRG1 XRCC3 FANCM CIT KIF24 LRCH3 MMRN1 CRACD CFAP54 ALMS1 BRCA2 GCC2 CEP295 LRBA NIPBL RBM18 KNL1 | 4.83e-05 | 1252 | 178 | 25 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | NHSL2 KIF1B ASH1L ZEB2 MMRN1 HOXC10 MAST4 ZFHX4 CEP295 VGLL4 TBX20 MGA CEP57 | 5.30e-05 | 417 | 178 | 13 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 6.87e-05 | 162 | 178 | 8 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.26e-05 | 210 | 178 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | TANC2 ENDOD1 ABCA1 KIF1B ASH1L APC CREBBP OTUD4 PLAG1 RPRD2 TBX20 | 1.12e-04 | 330 | 178 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | NCOA3 ANKFY1 KIF1B ASH1L SRCAP CREBBP MAST4 CEP295 VGLL4 CEP57 | 1.14e-04 | 275 | 178 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.23e-04 | 225 | 178 | 9 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.45e-04 | 230 | 178 | 9 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TPR EPC2 SHROOM3 ZNF280D MAP1A KIF1B WDR81 APC ADGRG1 C11orf24 XRCC3 FANCM KIF24 CRACD BPTF CFAP54 ALMS1 BRCA2 HEY1 GCC2 CEP295 IRS2 MDGA1 NIPBL KNL1 | 2.00e-04 | 1370 | 178 | 25 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR EPC2 ZNF280D MAP1A PRR5 APC ADGRG1 XRCC3 FANCM CIT KIF24 LRCH3 CRACD CFAP54 ALMS1 BRCA2 GCC2 CEP295 MDGA1 NIPBL KNL1 | 2.27e-04 | 1060 | 178 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.62e-04 | 249 | 178 | 9 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | TPR EPC2 ZNF280D TSHZ2 PLEKHA4 ADGRG1 CREBBP ALMS1 BRCA2 GCC2 CIPC LRBA KNL1 | 2.72e-04 | 492 | 178 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 2.86e-04 | 107 | 178 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K1 | ABI3 WDR81 SORBS1 ENPP4 ATE1 TMEM127 DENND2B EML3 IFNGR2 HIVEP3 WDR91 LMF2 CSF1 ARHGAP31 SUN2 WASF2 IFFO2 CREB3 | 2.95e-04 | 850 | 178 | 18 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.07e-04 | 311 | 178 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | NCOA3 ENDOD1 ANKFY1 TSHZ2 NHSL2 ASH1L SRCAP CREBBP ZEB2 MAST4 ADGRG2 CEP295 VGLL4 MAP3K21 MGA CEP57 KNL1 | 4.02e-04 | 797 | 178 | 17 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 4.27e-04 | 161 | 178 | 7 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | TPR ZNF280D TSHZ2 NHSL2 PLEKHA4 RNF213 CREBBP ZFHX4 BRCA2 GCC2 | 5.00e-04 | 331 | 178 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TANC2 TPR ABCA1 GATAD2A ANK3 MBOAT7 MAPT KIF1B APC ITGA5 IFI16 ZEB2 ZFHX4 OTUD4 PLAG1 AKAP10 TBX20 | 5.40e-04 | 818 | 178 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | ANKFY1 TSHZ2 NHSL2 ASH1L ZEB2 MAST4 ADGRG2 CEP295 MAP3K21 MGA CEP57 | 6.30e-04 | 404 | 178 | 11 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 6.33e-04 | 172 | 178 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | TPR EPC2 ABCA1 SHROOM3 MAP1A MYT1 KIF1B WDR81 ADGRG1 FANCM CIT HIVEP3 ALMS1 BRCA2 TJP1 GCC2 TLE2 LRBA NIPBL | 6.40e-04 | 986 | 178 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | NCOA3 ANKFY1 NHSL2 ASH1L SRCAP CREBBP ZEB2 MAST4 ADGRG2 CEP295 MGA | 6.56e-04 | 406 | 178 | 11 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TPR EPC2 ZNF280D TCOF1 MYT1 APC ADGRG1 RNF213 C11orf24 CIT WDR91 ZFHX4 BRCA2 GCC2 CEP295 LRBA MGA NIPBL KNL1 | 6.63e-04 | 989 | 178 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 6.89e-04 | 21 | 178 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | 7.88e-04 | 86 | 178 | 5 | GSM399442_100 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-07 | 188 | 187 | 9 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.34e-07 | 193 | 187 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-07 | 196 | 187 | 9 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-07 | 172 | 187 | 8 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-07 | 172 | 187 | 8 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 7.67e-07 | 120 | 187 | 7 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.33e-07 | 179 | 187 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 185 | 187 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.24e-06 | 186 | 187 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.35e-06 | 188 | 187 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.40e-06 | 189 | 187 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.46e-06 | 190 | 187 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.52e-06 | 191 | 187 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.77e-06 | 195 | 187 | 8 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.77e-06 | 195 | 187 | 8 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.77e-06 | 195 | 187 | 8 | bff726515ea9ce82c223e6c805000afe2e9b7206 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.99e-06 | 198 | 187 | 8 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.99e-06 | 198 | 187 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 199 | 187 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 199 | 187 | 8 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.14e-06 | 200 | 187 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.14e-06 | 200 | 187 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.14e-06 | 200 | 187 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.14e-06 | 200 | 187 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.61e-06 | 157 | 187 | 7 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.61e-06 | 157 | 187 | 7 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.67e-06 | 162 | 187 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 8.39e-06 | 172 | 187 | 7 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.09e-05 | 179 | 187 | 7 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.13e-05 | 180 | 187 | 7 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.17e-05 | 181 | 187 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 182 | 187 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 182 | 187 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 187 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.30e-05 | 184 | 187 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.35e-05 | 185 | 187 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-05 | 186 | 187 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.40e-05 | 186 | 187 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 186 | 187 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-05 | 187 | 187 | 7 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.50e-05 | 188 | 187 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 188 | 187 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 188 | 187 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.50e-05 | 188 | 187 | 7 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 188 | 187 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.50e-05 | 188 | 187 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-05 | 190 | 187 | 7 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 1.60e-05 | 190 | 187 | 7 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-05 | 190 | 187 | 7 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.60e-05 | 190 | 187 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.66e-05 | 191 | 187 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.66e-05 | 191 | 187 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-05 | 191 | 187 | 7 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.66e-05 | 191 | 187 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.66e-05 | 191 | 187 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.71e-05 | 192 | 187 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.71e-05 | 192 | 187 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.71e-05 | 192 | 187 | 7 | fdc741e1846cfd8ed741b160e3c611c310c5d36d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 193 | 187 | 7 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-05 | 193 | 187 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-05 | 193 | 187 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 193 | 187 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 1.77e-05 | 193 | 187 | 7 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 193 | 187 | 7 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 194 | 187 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.83e-05 | 194 | 187 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-05 | 194 | 187 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.83e-05 | 194 | 187 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.83e-05 | 194 | 187 | 7 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.89e-05 | 195 | 187 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 195 | 187 | 7 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 195 | 187 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 195 | 187 | 7 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 195 | 187 | 7 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.89e-05 | 195 | 187 | 7 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.89e-05 | 195 | 187 | 7 | 14a6466524c22920daa622fbc710daf1defb46c3 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 195 | 187 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD16+_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 195 | 187 | 7 | 7533822d2fe551f499b5b2fdec7172f56c79cb44 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-05 | 195 | 187 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 1.89e-05 | 195 | 187 | 7 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 197 | 187 | 7 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.02e-05 | 197 | 187 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.02e-05 | 197 | 187 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 197 | 187 | 7 | 61b1b10a017cbeb17f8529fcae66cba77ee2f115 | |
| ToppCell | facs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 197 | 187 | 7 | a1f7eec1aca03432caa8fe817ff6d24b29d4062d | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 2.02e-05 | 197 | 187 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-05 | 197 | 187 | 7 | 8e41e6cda38eace961cb1a56f4df24468c66b956 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 197 | 187 | 7 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 197 | 187 | 7 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 2.02e-05 | 197 | 187 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Sepsis-URO-Others|URO / Disease, condition lineage and cell class | 2.09e-05 | 198 | 187 | 7 | 6caab5266da666cfbe92ac1ace26ad2004e5aa09 | |
| ToppCell | Sepsis-URO-Others-RBC|URO / Disease, condition lineage and cell class | 2.09e-05 | 198 | 187 | 7 | d35e9d0952b3f7cd5d0d1a69bad2ae81af8eed50 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-05 | 198 | 187 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 2.09e-05 | 198 | 187 | 7 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 199 | 187 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | distal-3-Hematologic-Classical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-05 | 199 | 187 | 7 | cd7c304076d14315dc24cf56eb5e06b9426710be | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 199 | 187 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 200 | 187 | 7 | 7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.23e-05 | 200 | 187 | 7 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.23e-05 | 200 | 187 | 7 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| Drug | retinoic acid; Up 200; 1uM; HL60; HT_HG-U133A | 2.49e-06 | 145 | 181 | 9 | 1152_UP | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | ARHGAP32 ABCA1 APC RAP1GAP2 GMIP NIPAL3 SBF1 SUN2 SLC4A4 NIPBL | 4.20e-06 | 197 | 181 | 10 | 7130_DN |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; PC3; HT_HG-U133A | NCOA3 ANK3 MBOAT7 TOM1 SRCAP IFI16 DENND2B HOXC10 ERAP2 VGLL4 | 4.39e-06 | 198 | 181 | 10 | 1818_DN |
| Drug | LY294002; Down 200; 10uM; ssMCF7; HG-U133A | TCOF1 MBOAT7 MAPT ITSN1 C11orf24 GMIP TMEM127 WDR91 LMF2 RRP12 | 4.39e-06 | 198 | 181 | 10 | 401_DN |
| Drug | radicicol; Up 200; 0.1uM; HL60; HG-U133A | 2.51e-05 | 193 | 181 | 9 | 544_UP | |
| Drug | ST021200; Down 200; 10uM; PC3; HT_HG-U133A | 2.73e-05 | 195 | 181 | 9 | 7493_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; PC3; HT_HG-U133A | 2.84e-05 | 196 | 181 | 9 | 4467_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A | 2.96e-05 | 197 | 181 | 9 | 1909_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 3195_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 3829_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A | 2.96e-05 | 197 | 181 | 9 | 1441_UP | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 3.07e-05 | 198 | 181 | 9 | 7481_UP | |
| Disease | Malignant neoplasm of breast | NCOA3 NCOA6 LRRC37A2 SORBS1 XRCC3 ZEB2 PALB2 LMF2 CSF1 LRRC37A BRCA2 HEY1 ARHGAP29 MROH7 OSBPL11 USP54 LRBA NIPBL ZNF541 FOXP3 | 7.70e-06 | 1074 | 177 | 20 | C0006142 |
| Disease | breast cancer (implicated_via_orthology) | 1.43e-05 | 25 | 177 | 4 | DOID:1612 (implicated_via_orthology) | |
| Disease | Pancreatic carcinoma, familial | 1.74e-05 | 9 | 177 | 3 | C2931038 | |
| Disease | medulloblastoma (is_implicated_in) | 2.47e-05 | 10 | 177 | 3 | DOID:0050902 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.86e-05 | 152 | 177 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 9.02e-05 | 75 | 177 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | Bone marrow hypocellularity | 1.62e-04 | 18 | 177 | 3 | C1855710 | |
| Disease | reticulocyte count | ENDOD1 NCOA6 ABCA1 UBAP2 GATAD2A MAPT GRAMD1A ASH1L PLEKHA4 MFSD2B ARHGAP9 TSEN2 DENND2B PIKFYVE OTUD4 AKAP10 IRS2 | 1.96e-04 | 1045 | 177 | 17 | EFO_0007986 |
| Disease | synucleinopathy (biomarker_via_orthology) | 2.13e-04 | 4 | 177 | 2 | DOID:0050890 (biomarker_via_orthology) | |
| Disease | Medulloblastoma | 2.32e-04 | 50 | 177 | 4 | C0025149 | |
| Disease | prostate carcinoma | TANC2 SHROOM3 UBAP2 EXPH5 ADGRG1 RNF213 NIPAL3 TSEN2 TASOR2 MAST4 SUN2 PLAG1 MAP3K21 CRAMP1 KNL1 | 3.29e-04 | 891 | 177 | 15 | EFO_0001663 |
| Disease | Pancreatic Neoplasm | 3.49e-04 | 100 | 177 | 5 | C0030297 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 3.54e-04 | 5 | 177 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | Malignant neoplasm of pancreas | 3.82e-04 | 102 | 177 | 5 | C0346647 | |
| Disease | aspartate aminotransferase measurement | ABCA1 SHROOM3 MAPT BECN2 RNF213 ARHGAP9 ZC3H18 ALKBH5 WDR91 CSF1 ERAP2 ARHGAP29 PLAG1 LRBA SLC4A4 | 3.83e-04 | 904 | 177 | 15 | EFO_0004736 |
| Disease | Fanconi Anemia | 4.43e-04 | 25 | 177 | 3 | C0015625 | |
| Disease | Pancytopenia | 4.98e-04 | 26 | 177 | 3 | C0030312 | |
| Disease | renal overload-type gout | 5.28e-04 | 6 | 177 | 2 | EFO_0021525 | |
| Disease | Malignant tumor of breast | 5.58e-04 | 27 | 177 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 5.58e-04 | 27 | 177 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 5.58e-04 | 27 | 177 | 3 | cv:C0346153 | |
| Disease | pancreatic cancer (is_implicated_in) | 5.87e-04 | 112 | 177 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | platelet crit | GATAD2A MAP1A NHSL2 EXPH5 RNF8 MFSD2B ZC3H18 DENND2B CSF1 MAST4 ARHGAP29 OTUD4 PLAG1 RPRD2 IRS2 | 6.53e-04 | 952 | 177 | 15 | EFO_0007985 |
| Disease | Miller Dieker syndrome | 6.91e-04 | 29 | 177 | 3 | C0265219 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 8.43e-04 | 70 | 177 | 4 | EFO_0008082 | |
| Disease | eosinophil cationic protein measurement | 9.78e-04 | 8 | 177 | 2 | EFO_0010913 | |
| Disease | pentachlorophenol measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 9.87e-04 | 73 | 177 | 4 | EFO_0008360 | |
| Disease | Abnormality of radial ray | 1.01e-03 | 33 | 177 | 3 | C4228778 | |
| Disease | DDT metabolite measurement | 1.04e-03 | 74 | 177 | 4 | EFO_0007886 | |
| Disease | amnestic disorder (implicated_via_orthology) | 1.25e-03 | 9 | 177 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | Osteitis Deformans | 1.25e-03 | 9 | 177 | 2 | C0029401 | |
| Disease | longitudinal alcohol consumption measurement | 1.25e-03 | 9 | 177 | 2 | EFO_0007645 | |
| Disease | Mammary Carcinoma, Human | NCOA3 LRRC37A2 XRCC3 ZEB2 PALB2 CSF1 LRRC37A BRCA2 HEY1 FOXP3 | 1.33e-03 | 525 | 177 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | NCOA3 LRRC37A2 XRCC3 ZEB2 PALB2 CSF1 LRRC37A BRCA2 HEY1 FOXP3 | 1.33e-03 | 525 | 177 | 10 | C1257931 |
| Disease | Mammary Neoplasms | NCOA3 LRRC37A2 XRCC3 ZEB2 PALB2 CSF1 LRRC37A BRCA2 HEY1 FOXP3 | 1.37e-03 | 527 | 177 | 10 | C1458155 |
| Disease | urea measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0011005 | |
| Disease | Breast Carcinoma | NCOA3 LRRC37A2 XRCC3 ZEB2 PALB2 CSF1 LRRC37A BRCA2 HEY1 FOXP3 | 1.60e-03 | 538 | 177 | 10 | C0678222 |
| Disease | reticulocyte measurement | ENDOD1 ABCA1 UBAP2 GATAD2A MAPT GRAMD1A ASH1L PLEKHA4 MFSD2B ARHGAP9 TSEN2 DENND2B ZEB2 PIKFYVE IRS2 | 1.77e-03 | 1053 | 177 | 15 | EFO_0010700 |
| Disease | Mesothelioma | 1.91e-03 | 41 | 177 | 3 | C0025500 | |
| Disease | Childhood Medulloblastoma | 2.20e-03 | 43 | 177 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 2.20e-03 | 43 | 177 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 2.20e-03 | 43 | 177 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 2.20e-03 | 43 | 177 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 2.20e-03 | 43 | 177 | 3 | C0278876 | |
| Disease | Dental enamel hypoplasia | 2.27e-03 | 12 | 177 | 2 | EFO_1001304 | |
| Disease | Neurodevelopmental Disorders | 2.41e-03 | 93 | 177 | 4 | C1535926 | |
| Disease | Benign tumor of pancreas | 2.67e-03 | 13 | 177 | 2 | C0347284 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0802114 | |
| Disease | schizophrenia, anorexia nervosa | 3.01e-03 | 48 | 177 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | Fanconi anemia | 3.11e-03 | 14 | 177 | 2 | cv:C0015625 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 3.11e-03 | 14 | 177 | 2 | C0677776 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.19e-03 | 49 | 177 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | blood cobalt measurement | 3.25e-03 | 101 | 177 | 4 | EFO_0007577 | |
| Disease | vital capacity | TBX15 NCOA3 NCOA6 SHROOM3 MAPT MYT1 ATE1 EML3 RBM20 KCNH3 OTUD4 SLX4IP PLAG1 RPRD2 LRBA MYO18B | 3.26e-03 | 1236 | 177 | 16 | EFO_0004312 |
| Disease | alcohol consumption measurement | ZNF280D UNCX TSHZ2 MAPT CIT MMRN1 CNTNAP5 MLIP MAST4 ALMS1 TTLL6 XRN1 RPRD2 CIPC OLIG1 MGA | 3.42e-03 | 1242 | 177 | 16 | EFO_0007878 |
| Disease | anemia (implicated_via_orthology) | 3.57e-03 | 15 | 177 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | amygdala volume change measurement | 4.06e-03 | 16 | 177 | 2 | EFO_0021490 | |
| Disease | Polyposis, Adenomatous Intestinal | 4.06e-03 | 16 | 177 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 4.06e-03 | 16 | 177 | 2 | C2713443 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 4.06e-03 | 16 | 177 | 2 | C1257877 | |
| Disease | Prostatic Neoplasms | 4.20e-03 | 616 | 177 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.20e-03 | 616 | 177 | 10 | C0376358 | |
| Disease | serum IgG glycosylation measurement | ABI3 SORBS1 FAM90A27P CNTNAP5 SBF1 UMODL1 SUN2 ARHGAP29 MDGA1 | 4.48e-03 | 523 | 177 | 9 | EFO_0005193 |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 4.55e-03 | 111 | 177 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | cyclic adenosine monophosphate measurement | 4.59e-03 | 17 | 177 | 2 | EFO_0010473 | |
| Disease | alcoholic liver cirrhosis | 4.59e-03 | 17 | 177 | 2 | EFO_1000802 | |
| Disease | Adenomatous Polyposis Coli | 4.59e-03 | 17 | 177 | 2 | C0032580 | |
| Disease | oral motor function measurement | 4.59e-03 | 17 | 177 | 2 | EFO_0021793 | |
| Disease | non-alcoholic fatty liver disease | 4.92e-03 | 182 | 177 | 5 | EFO_0003095 | |
| Disease | tonsillectomy risk measurement | 4.95e-03 | 260 | 177 | 6 | EFO_0007924 | |
| Disease | heart failure | 5.27e-03 | 185 | 177 | 5 | EFO_0003144 | |
| Disease | creatinine measurement, glomerular filtration rate | 5.48e-03 | 117 | 177 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | Brugada syndrome | 5.72e-03 | 19 | 177 | 2 | MONDO_0015263 | |
| Disease | Pancreatic carcinoma | 5.72e-03 | 19 | 177 | 2 | C0235974 | |
| Disease | Pheochromocytoma | 5.72e-03 | 19 | 177 | 2 | C0031511 | |
| Disease | blood nickel measurement | 5.99e-03 | 120 | 177 | 4 | EFO_0007583 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLPLTSTLTALKTPA | 686 | Q5DID0 | |
| SASASTLQLSPPRTK | 536 | Q6N043 | |
| DEPRSRNTSAKLPSS | 136 | Q96P26 | |
| RPSSATNKALSPVTS | 726 | Q96L91 | |
| SAPSPTALKLATVAA | 751 | Q52LR7 | |
| TAPSLALLADSEKPS | 786 | Q9NR48 | |
| PPLRRSSSVKETSAN | 2681 | Q96N23 | |
| AAATQKTSSPLTRSP | 146 | Q6UXZ3 | |
| ITRTSPAAKSPSAQL | 1171 | Q14203 | |
| LTVASRNSPASPLKE | 271 | O43572 | |
| RLETKSLSSSVLPPS | 291 | Q6P6C2 | |
| RTLNSTSPFPSKELA | 241 | O95477 | |
| DTDNSSLSPPPAKLS | 41 | Q8IZP9 | |
| AASASTPPSNRKALS | 3031 | Q8TCU4 | |
| SDKPFLNSDLRRSPS | 41 | Q86XR8 | |
| LNSDLRRSPSKPTLA | 46 | Q86XR8 | |
| ALQDLLRTLKSPSSP | 2066 | Q92793 | |
| QSLKTIASSEPSLSP | 1621 | Q96M86 | |
| GNSPSSQRLPSKSSL | 366 | P78524 | |
| SQRLPSKSSLDPAVN | 371 | P78524 | |
| SSVPKSTNDRDATPL | 1381 | Q12830 | |
| SLLAPPSSRRKESST | 1331 | O14578 | |
| STPSSSPSLRKRLQL | 11 | Q96CP6 | |
| SDSPSRSPKTLLGSD | 281 | Q5VWP3 | |
| PSSKALLIPTSNSSL | 196 | Q68CQ1 | |
| NDKILPISLEPSSST | 116 | Q96H35 | |
| ISLKSPRELPSASTS | 976 | Q5T481 | |
| SQTRKADTALASIPP | 941 | Q01804 | |
| SSSAAKLLSPRRTAP | 761 | Q9ULD8 | |
| LSRKSIKAPATPASA | 166 | Q9P2A4 | |
| ILSPSPSQLSESKEL | 396 | A5PLL1 | |
| SSERPPLSTLTLKEA | 546 | Q5JPF3 | |
| PLPKEAASLTSLADS | 526 | Q9P2R3 | |
| FRLTNTTAPPALKLS | 231 | Q8NFP4 | |
| SPSPKLQNSASATAL | 546 | Q86YP4 | |
| SSSLSKSPEKNPRAR | 2926 | Q8WXI7 | |
| RLPFSAAKSLINSPS | 1341 | O60309 | |
| LKSDDRPNALLSSPA | 571 | Q96II8 | |
| SAALKLQQLPPTSSS | 6 | Q6P499 | |
| ELSSPISPKSLQSDT | 2016 | P78559 | |
| RLPFSAAKSLINSPS | 1341 | A6NM11 | |
| RLPFSAAKSLINSPS | 1341 | A6NMS7 | |
| APRKDSTLSAVPQSS | 176 | Q9BZS1 | |
| AASRKPRTLLPSTSN | 1486 | Q8IWI9 | |
| PLKSSLTPSSQDDSN | 471 | Q96S38 | |
| PSLNSSPLDIRKKLS | 371 | Q9P107 | |
| ARTSEDSLLKSTLPP | 71 | Q13201 | |
| DSLLKSTLPPSETSA | 76 | Q13201 | |
| SIPKSLSDSLSPSLS | 1521 | O60333 | |
| PASKVSSLSPSLSQI | 2061 | Q5HYC2 | |
| DVSLSPLNSKSESLP | 1146 | Q8IYD8 | |
| KRSTLLPPEASEGSS | 311 | O94919 | |
| LKSSHQTPTLSARLP | 211 | A6NNH2 | |
| TSLSNPDSSTGRLLK | 381 | Q1X8D7 | |
| FRSDSSSSLPPKLLL | 16 | Q9Y6X5 | |
| LSSPSRPTQKTLCSL | 66 | Q8TDV5 | |
| PLPATTTKSLLFNAR | 31 | Q6KC79 | |
| SEELSANPLSPLSAK | 446 | Q9P1Y6 | |
| ANPLSPLSAKRRALS | 451 | Q9P1Y6 | |
| SSPKRIQSSPGALSE | 566 | Q5T7B8 | |
| LASTKSPSRNLFVLP | 206 | Q8IWV1 | |
| ESPGSRSSNAKLPSV | 1766 | P50851 | |
| RSSNAKLPSVPTVDS | 1771 | P50851 | |
| QLPSKSRSSSLTLPS | 41 | A0A1B0GTW7 | |
| SPSRRKAASQPTSLA | 451 | Q96N66 | |
| SAALPDSSPSKNSSL | 881 | Q8NEV8 | |
| SKLAEPLRKSLSNPT | 756 | Q8NG31 | |
| TPKTPSRDASSRLSL | 481 | A6NFX1 | |
| SSSSTTAPLLPKAAR | 56 | Q8TAK6 | |
| SLSRPKSLLVSSPST | 581 | A7KAX9 | |
| PSSSKDRLFLPTRSQ | 316 | P34949 | |
| PSESLTASSPLKLNE | 336 | Q15722 | |
| SSLSRAKSEPFRISP | 1141 | O95248 | |
| SRALQDSSLPKITPA | 656 | Q2TAC6 | |
| SPKNQPSALLSASAS | 206 | Q8WX93 | |
| SQPKSLSLEATSPLS | 376 | Q86YC2 | |
| DLSSSKEPSNSLNLP | 1536 | Q14686 | |
| APSRSSASSGPQILK | 896 | P08648 | |
| RSRTDSLAATPPAAK | 341 | Q9Y4H2 | |
| TPKPLSLKSDRSTNN | 991 | Q52LW3 | |
| KLSGSSESRSLPAAP | 16 | A8MW95 | |
| KTSPTLDSANDLPRS | 6 | Q9Y2I7 | |
| PPKGRSFSSLESSLD | 81 | O95704 | |
| SNFLSASSPLPASAK | 341 | P09603 | |
| TSENSLPRISSLPKS | 441 | P51587 | |
| NTALTPKLQASRSFP | 6 | A1L170 | |
| KAKPRQESPSSASAL | 651 | Q6ZU35 | |
| KQAPSTRRDSAEPSS | 911 | Q6ZU35 | |
| VTDSTSAPAPKLALR | 816 | Q15811 | |
| QASLRSSKTFPPSSA | 786 | Q96RY5 | |
| SLAKSPSVKNDPLSS | 931 | Q8IWJ2 | |
| PLKSNSDSARLPISS | 671 | Q9Y653 | |
| RTSSPVKSSLFLAPS | 1871 | Q12955 | |
| LIKGSADRNSPSPSS | 476 | Q5TF58 | |
| PSLSKRDEGSSPSLA | 51 | Q9NYD6 | |
| STPSSSFLTTLKPRL | 546 | Q16666 | |
| SAPSLTASLKELSLP | 206 | O15021 | |
| TKSDSLPSFRVSTLP | 2516 | O15021 | |
| PFRSNSISLDNLKPS | 191 | P38484 | |
| RSSPPSSQFKATLLE | 276 | O95260 | |
| TKDSLNSSRPISKPA | 426 | Q6P179 | |
| SASKLSPPLLSSVAS | 246 | Q9Y5J3 | |
| SSSSSSPSERPRQKL | 156 | Q32P44 | |
| LSKSPSRSSPLHLNV | 5201 | Q8NDH2 | |
| SSLLSSLPQDKIFSP | 836 | Q9Y4K1 | |
| SRPLSLKSSSTPKQL | 381 | Q8IXS0 | |
| LVTPDSSALLPSAKA | 891 | Q9C0D2 | |
| SLLSPPASLNILSSS | 56 | O43889 | |
| KSAFPPSVRALLDSS | 886 | Q5VT52 | |
| LPPPSSSASKLRTNL | 566 | Q92630 | |
| GKDSTSRELPSATPN | 116 | Q9BUN1 | |
| LKPETLLASRSPSSN | 921 | P80192 | |
| DSKARLSSSLPSATL | 246 | Q8WYK1 | |
| VSPLDLLPSKSTASL | 886 | A6NGG8 | |
| PPLKSRSFSLASSSN | 166 | Q9BXB4 | |
| LAAPAPTARNKLTSE | 111 | P41218 | |
| KSFQSLVLSSLPDPS | 721 | Q4G0U5 | |
| LAAKTSFSLSRPSSP | 901 | Q8N1G1 | |
| LSRSRPSFTISDPKL | 71 | Q8NCE0 | |
| SNSKSKPNLPSESRS | 446 | Q08170 | |
| KPNLPSESRSRSKSA | 451 | Q08170 | |
| LANSSDATLPDRPLS | 31 | Q684P5 | |
| SSQKKFSRPLLPSAA | 881 | A5PKW4 | |
| FPLKLLSASSLNTPS | 6 | B4DYI2 | |
| ASTPSDNLDPKLTAL | 196 | O76064 | |
| SPRKSAEPSANTTLV | 156 | Q13428 | |
| DPPSDLLLLKQSNSS | 926 | P12259 | |
| EKSPPRTRSANSTLA | 606 | Q9BU23 | |
| KTASSRSILPDLLSP | 311 | Q9C0I9 | |
| LDKRRSLNSSSSSPP | 531 | Q5TCX8 | |
| KSRLSFDLPLTSSPN | 766 | Q5HYW2 | |
| SRPSAAELLKTTNPL | 1191 | Q5HYW2 | |
| FPLKLLSASSLNAPS | 6 | Q5VVP1 | |
| SLSSLSPKKPTRAVN | 21 | Q9H4M7 | |
| SSPSLSDLGKREPAA | 11 | P85299 | |
| TDLPRKLSSQALPSF | 866 | Q587J7 | |
| FPLKLLSASSLNAPS | 6 | Q8IWB4 | |
| PRLAASPEKLSASQS | 526 | Q96SF7 | |
| SLLSTLSSPGPKLDN | 536 | Q9Y6Q9 | |
| ASSLSSLREPSLQPR | 1136 | Q8TF72 | |
| SKLDLERSSSQLGSP | 1731 | Q9HCD6 | |
| FPLKLLSASSLNTPS | 6 | P0DKV0 | |
| SSETSSLSLVPPKDL | 2571 | Q6ZRS2 | |
| SEKNLSLTPSAPSLT | 2596 | Q6ZRS2 | |
| LLDSLRSTSSPAKRP | 821 | Q5JTH9 | |
| AESSLPPSAKLRRNA | 151 | Q5VYV7 | |
| DTSSPQSRPLASDLK | 806 | Q8TBZ0 | |
| NNPLRLSESKKSSPT | 1111 | Q96JN2 | |
| KLSQLPRTSSPSTAS | 2341 | P25054 | |
| PSPESSILSSRKENG | 401 | Q96JQ2 | |
| ERLGPSLSSSEPTKA | 191 | Q9C0C6 | |
| SFPSSLSKERQSLPD | 671 | G9CGD6 | |
| PSLSTALAQVPKSSA | 186 | Q96F05 | |
| ALAQVPKSSALPRTA | 191 | Q96F05 | |
| TKNSLDASRPAGLSP | 136 | Q14135 | |
| SLPSSELLSKPFTNT | 271 | Q6DJT9 | |
| SKSSISISDPLNTPA | 401 | Q6DJT9 | |
| AALDKSPSLSPQLAA | 16 | Q8NEY3 | |
| FPLKLLSASSLNAPS | 6 | Q5VYP0 | |
| KSASSELASLPLSPA | 101 | Q63HN8 | |
| SQAKLRESTPGDSPS | 461 | Q5T6F2 | |
| ELSPKNLLSPSSFKA | 2716 | Q86UP3 | |
| PLPSRTNLARSKSVS | 101 | Q9UK80 | |
| KALSPNSTISSAPKD | 631 | Q9UH99 | |
| FPLKLLSASSLNAPS | 6 | Q5TZJ5 | |
| QKSRARSSSLPPAST | 471 | Q0P670 | |
| LPLSRSASQTKLRSP | 166 | Q9C0H9 | |
| FPLKLLSASSLNAPS | 6 | Q5VU36 | |
| SSLDDVSLASTPKRP | 631 | P12270 | |
| AKAADRLPNLSSPSA | 451 | O60784 | |
| LNLSSPKRSKPDASS | 291 | A6NJL1 | |
| PKSLPRSQSREDSNS | 296 | Q9NYB5 | |
| ATLPLPARSSSLKSS | 496 | Q9BX66 | |
| LPLSETSSRPAKSQE | 1571 | Q5T1R4 | |
| ALNLSSPKRSKPDAS | 291 | Q9BUG6 | |
| PRESSSASLKSSPIA | 1646 | Q8IZH2 | |
| KSPSSAKSRLQTAPV | 551 | P10636 | |
| RSVSTDNLSPSLLKP | 141 | Q9BRR9 | |
| SASSSPKRPSVERSN | 136 | O75764 | |
| PSGDNLLSSKLERPS | 1316 | Q2M1Z3 | |
| TSAKPFSSLPDLRNI | 586 | Q8N841 | |
| NLSSSKLEPSKPNFS | 601 | Q8N841 | |
| LPSRSVSKPSLFSSV | 181 | Q9NRE2 | |
| KSTERLEPASSPLAS | 2216 | Q8IUG5 | |
| RSTNTSPLSREKLPS | 2231 | Q8IUG5 | |
| PKSSLPAVSDARSDL | 426 | Q9Y6W5 | |
| SDRRSVASSQPAKPT | 171 | Q07157 | |
| SNDSPASSSSRPLKV | 316 | Q8N1G0 | |
| AEASLLKLSPATPTS | 366 | Q8N1G0 | |
| SSSSILKPLISPAAE | 76 | Q9Y6R1 | |
| QQDPEKRPSASSLLS | 351 | Q9C0K7 | |
| PKRTASRADNSSDSP | 371 | Q5VWN6 | |
| SPKPQLSSRANAFSI | 6 | Q9UMR3 | |
| SNSRSPSLERSSKPL | 701 | O60315 | |
| LAAKPAPSTDSVALR | 326 | Q04725 | |
| FLSSLLPQSKKSPSR | 261 | A4D1P6 | |
| SGPDLKRLTNLSSPE | 31 | O43542 | |
| SALPKQPERSLASAL | 21 | O75204 | |
| LLEPPSQATTKLSSE | 1896 | Q562E7 | |
| EKPNSDSLSLASITP | 171 | Q6SJ96 | |
| PLSKSSSSPELQTLQ | 1381 | P49815 | |
| SASSRSPAPAQTRKE | 741 | Q86VM9 | |
| SSSPNAGSKRTPELL | 1266 | Q9H0D2 | |
| SLLSDSPPRRKAASN | 336 | A6NJT0 | |
| APRNASKPSSSTNRL | 491 | Q70EL1 | |
| SAPQHSSPSRSALKL | 941 | Q70EL1 | |
| DPSKSSSNSDRILRP | 531 | Q01538 |